Dow Inc. is reportedly exploring options to sell its stake in Sadara Chemical Co., a $20 billion chemicals joint venture with Saudi Aramco. This strategic review is driven by Dow's efforts to restructure its portfolio amidst a prolonged downturn in the chemicals industry. Saudi Aramco, which holds the majority stake, may acquire Dow's 35% share, or other investors could submit bids.

Dow is reportedly considering selling its stake in a $20 billion chemicals joint venture, Sadara Chemical Co., with Saudi Aramco amidst an industry downturn and rising costs. Saudi Aramco or other investors could potentially acquire Dow's share in Sadara, which operates a significant chemicals and plastics complex in Saudi Arabia. This move follows ongoing challenges in the chemicals industry, supply chain disruptions, and Dow's strategic review of non-core assets to boost profitability.

Engineers Gate Manager LP significantly increased its stake in Liberty Media Corporation - Liberty Formula One Series C (FWONK) by 893.8% in Q2 2026, making it their third-largest holding. Despite missing Q2 earnings and revenue estimates, analysts maintain a "Moderate Buy" consensus with an average price target of $118.00. The stock currently trades at $94.95, reflecting a market capitalization of $21.3 billion.

Ball Corporation (NYSE:BALL) has appointed Darlene J. Nicosia and Sherry L. Buck to its board of directors, strengthening the board's expertise. Nicosia brings over 30 years of food and beverage industry experience, previously holding leadership roles at The Coca-Cola Company, Inc., while Buck, a former CFO of W. L. Gore & Associates, Inc., adds extensive financial and operating experience. These appointments are expected to bolster the board's capabilities in supporting management.

This article provides a pre-market analysis of S&P500 stocks on September 9, 2026, highlighting the top gainers and losers. META, DOW, KEY, and HUM showed significant gains, while CASY, KMB, VRT, GOOGL, INTC, AMAT, VMC, GOOG, and KLAC experienced declines. The article also mentions recent press releases for CASY and INTC.

The National Independent Venue Association (NIVA) and several Live Nation competitors, including AEG and SeatGeek, have formally objected to the Department of Justice's proposed antitrust settlement with Live Nation. They argue the settlement fails to address Live Nation's monopoly effectively and does not serve the public interest. NIVA is pushing for structural remedies such as a tour cap, divestiture of Ticketmaster and artist management businesses, and financial compensation for independent stages.

Corning has secured a multi-billion dollar deal with Verizon, spanning 2027 to 2032, to provide over 80 million miles of high-density optical fiber and connectivity solutions. This agreement will support Verizon's broadband expansion to 40-50 million passings and its long-haul network buildout for AI infrastructure. The deal also involves expanding Corning’s U.S. manufacturing to meet the demand for its specialized Contour Flow Cable, designed for maximizing network capacity within existing conduits.

Argus has increased its price target for Air Products & Chemicals Inc. (NYSE: APD) to $329 from $316, maintaining a Buy rating. The firm cited improving fundamentals despite near-term challenges, highlighting sales, earnings, and margin EBITDA improvements. This adjustment follows Air Products raising its full-year guidance and increasing its dividend, along with positive revisions from other analysts and S&P Global Ratings due to strategic project exits.

Gartner's latest Magic Quadrant for container management indicates that the "big three" hyperscalers—Google, Microsoft, and AWS—maintain their leadership due to enterprise-grade standardization for AI and distributed fleets. While each leader has strengths in AI and execution, they also face individual challenges such as integration complexity or fragmented strategies. The report also highlights other players like Huawei, Alibaba, Red Hat, and SUSE, along with "challengers" including Tencent, Nutanix, and Broadcom, assessing their progress and specific capabilities in the evolving cloud and container management landscape.

Guggenheim has increased its price target for Ideaya Biosciences (NASDAQ:IDYA) to $57 from $54, maintaining a Buy rating, based on upcoming DLL3 data. The firm anticipates updated China Phase 1 data and initial global Phase 1 data for IDE849 in SCLC/NEC in the second half of 2026, leading to revised market assumptions for DLL3 and MTAP-del. Ideaya recently completed a public offering raising $345 million and initiated a Phase 1 clinical trial for IDE892, while Citizens also reiterated a Market Outperform rating.